Skip to main content
An official website of the United States government

MelaNostrum Consortium Members

Criteria for Membership

For investigators not part of a group already working in the Consortium and potentially bringing with him/her other people from their group:

  • The candidate must contribute data and/or biospecimens from melanoma patients (sporadic and/or familial, and possibly healthy controls) for the Consortium's projects. A brief description of the studies and related material that the candidate can contribute should be made available to all MelaNostrum PIs for their consideration.
  • The candidate must respect absolute confidentiality about any discussion of data/projects within the Consortium. Failure to observe this requirement may result in exclusion from the Consortium.
  • The candidate can be introduced by an existing member of MelaNostrum who can speak for his/her high quality of work. A candidate may alternatively approach the Consortium directly with the request to participate, in which case the decision to accept the request will be determined by the MelaNostrum PIs.
  • The candidate or a person from his/her group should strive to participate in the regular video-calls of the Consortium and attend each annual meeting in person.
  • The decision on whether to accept a new member or not should be made collegially by the MelaNostrum PIs. The decision can be communicated to Dr. Maria Teresa Landi privately by email and if consensus is not reached and more discussion is required, a decision may be postponed to the Consortium annual meeting.

If the candidate is a member of a group already working in MelaNostrum, it is enough if the PI who invites the person explains why he/she wants to bring this person and the type of expertise that this candidate can bring (e.g. in genetics, statistics, molecular biology, pathology).

United States

Bethesda

Department of Health and Human Services
National Institutes of Health
National Cancer Institute, Division of Cancer Epidemiology and Genetics

Croatia

Zagreb

Department of Dermatology and Venereology, Sestre 

Milosrdnice University Hospital Centre
School of Dental Medicine, University of Zagreb
 

Cyprus

Nicosia

Nicosia Department of Electron Microscopy/Molecular Pathology
The Cyprus Institute of Neurology and Genetics
The Cyprus School of Molecular Medicine

France

Nice

Laboratory of Clinical and Experimental Pathology, Nice University Hospital
Nice Hospital-integrated Biobank, University of Côte d'Azur

Centre Méditerranéen de Médecine Moléculaire 

Dermatology and skin cancer Department, University Hospital of Nice 

Greece

Athens

National and Kapodistrian University of Athens, 1st
Department of Dermatology and Venereology, School of Medicine Andreas Sygros Hospital

Italy

Cesena

Department of Dermatology Maurizio Bufalini Hospital

Florence

Histopathology and Molecular Diagnostics Careggi University Hospital

L'Aquila 

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila

Genoa

University of Genoa-Department of Internal Medicine and Medical Specialties
IRCCS Ospedale Policlinico San Martino- Cancer Genetics Unit

IRCCS Ospedale Policlinico San Martino- Medical Oncology Unit

Milan

Department of Experimental Oncology and Molecular Medicine
Fondazione IRCCS Istituto Nazionale dei Tumori

Rome

Dermatology, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Università Cattolica del Sacro Cuore

San Gallicano Dermatological Institute – IRCCS, IFO

Padua

Veneto Institute of Oncology IOV - IRCCS Immunology and Diagnostics Molecular Oncology Unit

Perugia

Medical Oncology Unit, University of Perugia

Spain

Barcelona

Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS
Universitat de Barcelona

Hospital Universitari Germans Trias i Pujol. Badalona

Madrid

Servicio de Dermatología Hospital 12 de Octubre

València

Instituto Valenciano de Oncología

Brazil

Barretos

Barretos Cancer Hospital

Rio de Janeiro

Instituto Nacional de Câncer – INCA

Sao Paulo

AC Camargo

Colombia

Bogota

FICMAC, Lobaratorio de investigacion y diagnostic en Cancer

Colombia National Cancer Institute

Peru

Lima

Universidad Cientifica del Sur - UCSUR
Instituto Nacional de Enfermedades Neoplásicas
 

Algeria

Constantine

Department of Pathology, University of Constantine

  • Updated:
Email